Abstract Details
|
Christopher Oustwani, MD
(Northwestern University Feinberg School of Medicine Department of Radiology)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Yasaman Kianirad, MD (University of Illinois At Chicago) | Dr. Kianirad has nothing to disclose. |
| Tanya Simuni, MD, FAAN (Northwestern University Feinberg School of Medicien) | Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation. |
| No disclosure on file |